How Orakl Oncology is using DINOv2 to accelerate cancer treatment discovery
Summary
Orakl Oncology is leveraging the DINOv2 model to integrate machine learning with experimental insights, aiming to accelerate cancer treatment discovery and drug development.
Similar Articles
How DINO and SAM are Helping Modernize Essential Medical Triage Practices
Researchers at the University of Pennsylvania are using AI models like DINO and SAM to automate and modernize medical triage in emergency response.
@OpenAI: Rare disease diagnosis is challenging, as sequencing can surface millions of variants, and medical knowledge changes co…
OpenAI highlights how o3 Deep Research can aid rare disease diagnosis by integrating clinical features, inheritance patterns, variant evidence, and scientific literature into actionable hypotheses for specialists.
Orc (working name) - auditable and declarative AI workflow
The developer is seeking feedback on "ORC," an early-stage orchestration-as-code tool that uses a declarative DSL to define, validate, and version control LLM workflows. Aimed at users combining local and cloud models, it replaces complex Python scripts with auditable, Terraform-like definitions for agents and tool execution.
Treatment Response Optimized Clinical Decision Support AI System via Digital Twin Simulation
This paper presents an online adaptive clinical decision support AI system that integrates treatment effect estimation, digital twin simulation, and reinforcement learning to recommend treatments in a safe, clinician-supervised manner, validated on a synthetic simulator and the TCGA ovarian cancer dataset.
Turning scattered evidence into discovery decisions for life sciences
OpenAI’s new life-science model “GPT-Rosalind” inside Codex autonomously ranks asthma drug targets by orchestrating specialist sub-agents that merge genetics, transcriptomics, safety and IP data into a single evidence-backed decision.